PROCEPT director granted RSUs and stock options

PROCEPT BioRobotics Corp director Elisabeth Sandoval received new equity compensation awards.

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp director Elisabeth Sandoval received new equity compensation awards. On June 9, 2026, she was granted 3,315 restricted stock units (RSUs), each representing one share of common stock, and stock options for 5,853 shares at an exercise price of $28.78 per share.

The RSUs and options vest in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, subject to her continued service. After the RSU grant, Sandoval directly owns 15,876 shares of common stock. The newly granted options expire on June 8, 2036.

Insider Trade Summary

Grant/Award: 9,168 shares

Grant/Award 2 txns

Insider Little Elisabeth Sandoval

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	5,853	$0.00	$0.00
Grant/Award	Common Stock	3,315	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 5,853 contracts (Direct); Common Stock — 15,876 shares (Direct)

Footnotes (2)

1. F1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
2. F2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Key Figures

RSUs granted: 3,315 shares Stock options granted: 5,853 shares Option exercise price: $28.78 per share +3 more

6 metrics

RSUs granted 3,315 shares Restricted stock units granted on June 9, 2026

Stock options granted 5,853 shares Options on common stock granted on June 9, 2026

Option exercise price $28.78 per share Strike price for newly granted stock options

Shares owned after grant 15,876 shares Common stock directly owned following RSU award

Option expiration date June 8, 2036 Expiration for the 5,853-share stock option grant

Grant date June 9, 2026 Date RSUs and stock options were awarded

Key Terms

restricted stock units (RSUs), Stock option, vest in full, annual meeting, +1 more

5 terms

restricted stock units (RSUs) financial

"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Stock option financial

"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date..."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

vest in full financial

"The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting..."

annual meeting financial

"Vests in full on the earlier to occur of the one-year anniversary of the grant date, or the date of the next annual meeting following the grant date."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

exercise price financial

"The Stock option was granted on June 9, 2026, with an exercise price of 28.78 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PROCEPT BioRobotics (PRCT) report for Elisabeth Sandoval?

PROCEPT BioRobotics reported that director Elisabeth Sandoval received equity compensation awards. She was granted 3,315 restricted stock units and stock options for 5,853 shares, both vesting based on continued service and key future dates tied to the company’s annual meeting.

How many PROCEPT BioRobotics (PRCT) RSUs did Elisabeth Sandoval receive?

Elisabeth Sandoval received 3,315 restricted stock units from PROCEPT BioRobotics. Each RSU represents a contingent right to one share of common stock, vesting in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, subject to continued service.

What are the terms of Elisabeth Sandoval’s new stock options at PROCEPT BioRobotics (PRCT)?

Sandoval was granted stock options for 5,853 shares of PROCEPT BioRobotics common stock at an exercise price of $28.78 per share. These options vest in full on the earlier of one year from grant or the next annual meeting, and expire on June 8, 2036.

When do Elisabeth Sandoval’s PROCEPT BioRobotics (PRCT) RSUs and options vest?

Both the RSUs and stock options vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the date of the next annual meeting, provided Sandoval continues in service through the applicable vesting date under the award terms.

How many PROCEPT BioRobotics (PRCT) shares does Elisabeth Sandoval hold after this Form 4?

Following the RSU grant, Sandoval directly holds 15,876 shares of PROCEPT BioRobotics common stock. This figure reflects her ownership after the reported acquisition transaction and helps investors understand the scale of her current direct equity position in the company.

Are Elisabeth Sandoval’s PROCEPT BioRobotics (PRCT) grants open-market purchases or compensation awards?

The transactions are compensation-related awards, not open-market purchases. The Form 4 uses code “A” for grant or award, covering 3,315 restricted stock units and options for 5,853 shares, both provided at no cash cost per share on the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Little Elisabeth Sandoval

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A(1)		3,315	A	$0	15,876	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$28.78	06/09/2026		A		5,853		(2)	06/08/2036	Common Stock	5,853	$0	5,853	D

Explanation of Responses:

1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Elisabeth Little	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)